The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
WCLC 2021 | Integrating lung cancer screening with smoking cessation
Matthew Steliga, MD, University of Arkansas for Medical Sciences, Little Rock, AR, outlines the benefits of an integrated lung cancer screening and smoking cessation program. Dr Steliga reports that around 71% of patients attending lung cancer screenings are actively smoking, providing an opportunity for lung cancer prevention. By training nurses in tobacco cessation counselling, the clinic is able to offer counselling to all patients at the same time as their lung cancer screening, with over 95% of patients agreeing to participate. At a years follow-up, roughly 20% of patients have achieved smoking cessation. This interview took place during the IASLC World Conference on Lung Cancer (WCLC) virtual meeting 2021.
